Remove keyword investment
article thumbnail

How to Increase SEO on Google Ads for the Pharma Industry

Pharma Marketing Network

Here are some tips on how to increase SEO on Google Ads for the pharma industry: Use relevant keywords: When you’re creating your Google Ads campaigns, make sure to use relevant keywords. You can use Google’s Keyword Planner tool to help you find relevant keywords.

article thumbnail

Google Ads Optimization for the Pharma Industry

Pharma Marketing Network

Use relevant keywords: When you create your ad groups, use relevant keywords that are likely to be used by people who are interested in your products or services. It should also be relevant to your target audience and the keywords you’re targeting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

Tyson School of Medicine Slides Keywords Pragmatic Clinical Trial, GGC4H, Prevention Key Points Guiding Good Choices for Health Study (GGC4H) is about the Guiding Good Choices (GGC) intervention, a group-based program for parents and caregivers of younger adolescents (ages 9-14).

article thumbnail

Pharma brands must ‘up the ante’ in their digital presence

pharmaphorum

Ensure keywords used are relevant for your audience – medical terminology for professionals and informational keywords providing solutions to ailments for consumers. As with Google, use target keywords relevant to your audience. Also, it is vital that all adverts and landing pages add value and are easily digestible.

Branding 124
article thumbnail

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Rethinking Clinical Trials

DCTs are not only more convenient for trial participants, but they often provide a positive return on investment for the trial itself. As IRBs and ethics committees review of DCTs, they can use newly developed recommendations for what should be submitted and discussions that should occur once the appropriate documents are submitted.

Trials 130
article thumbnail

Grand Rounds Ethics and Regulatory Series September 9, 2022: Building An Academic Learning Health System: Why Is It So Hard? (Steven Joffe, MD, MPH)

Rethinking Clinical Trials

People had to very quickly decide where are our priorities, invest resources, do clinical trials, move into an environment with little patient/provider contact, and suddenly folks from multiple parts of the institution were together making decisions. Steven Joffe, MD, MPH. Art and Ilene Penn Professor and Chair. Key Points.

article thumbnail

Grand Rounds August 12, 2022: Equitably Including Diverse Participants in Pragmatic Clinical Trials (Consuelo H. Wilkins, MD, MSCI)

Rethinking Clinical Trials

Because the system and structures have not been built equitability, we will need to invest more and have more transparency and accountability at every level, from the investigator, funder, publisher and journals. Senior Vice President and Senior Associate Dean. for Health Equity and Inclusive Excellence. Professor of Medicine. Key Points.